Nitric oxide (NO) mediates cellular signaling pathways that regulate a plethora of physiological processes. One of the signaling mechanisms mediated by NO is through S-nitrosylation of cysteine residues in target proteins, which is now regarded as an important redox-based physiological action. Deregulation of the protein S-nitrosylation upon nitrosative stress, however, has also been linked to various human diseases, such as neurodegenerative disorders. Between these physiological and pathophysiological roles, there are mechanisms whereby a milder level of nitrosative stress provides S-nitrosylation of some proteins that counteracts the pathological processes, serving as a negative feedback mechanism. In addition, NO has recently emerged as a mediator of epigenetic gene expression and chromatin changes. In this review, these molecular mechanisms, especially those in the central nervous system and neurodegenerative disorders, are described. Antioxid. Redox Signal. 14, 1493–1504.
Get full access to this article
View all access options for this article.
References
1.
AlarconJM, MalleretG, TouzaniK, VronskayaS, IshiiS, KandelER, BarcoA. Chromatin acetylation, memory, and LTP are impaired in CBP+/− mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration. Neuron, 42:947–959. 2004.
2.
AldertonWK, CooperCE, KnowlesRG. Nitric oxide synthases: structure, function and inhibition. Biochem J, 357:593–615. 2001.
3.
Anne-LaurenceB, CarolineR, IrinaP, Jean-PhilippeL. Chromatin acetylation status in the manifestation of neurodegenerative diseases: HDAC inhibitors as therapeutic tools. Subcell Biochem, 41:263–293. 2007.
4.
BaeBI, HaraMR, CascioMB, WellingtonCL, HaydenMR, RossCA, HaHC, LiXJ, SnyderSH, SawaA. Mutant huntingtin: nuclear translocation and cytotoxicity mediated by GAPDH. Proc Natl Acad Sci U S A, 103:3405–3409. 2006.
5.
Bal-PriceA, BrownGC. Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J Neurosci, 21:6480–6491. 2001.
6.
BenharM, ForresterMT, StamlerJS. Protein denitrosylation: enzymatic mechanisms and cellular functions. Nat Rev Mol Cell Biol, 10:721–732. 2009.
BrenmanJE, ChristophersonKS, CravenSE, McGeeAW, BredtDS. Cloning and characterization of postsynaptic density 93, a nitric oxide synthase interacting protein. J Neurosci, 16:7407–7415. 1996.
9.
BrownGC, Bal-PriceA. Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol Neurobiol, 27:325–355. 2003.
10.
BurkeJR, EnghildJJ, MartinME, JouYS, MyersRM, RosesAD, VanceJM, StrittmatterWJ. Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nat Med, 2:347–350. 1996.
11.
CalabreseV, CorneliusC, RizzarelliE, OwenJB, Dinkova-KostovaAT, ButterfieldDA. Nitric oxide in cell survival: a janus molecule. Antioxid Redox Signal, 11:2717–2739. 2009.
12.
CarrozzaMJ, UtleyRT, WorkmanJL, CoteJ. The diverse functions of histone acetyltransferase complexes. Trends Genet, 19:321–329. 2003.
13.
ChoDH, NakamuraT, FangJ, CieplakP, GodzikA, GuZ, LiptonSA. S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury. Science, 324:102–105. 2009.
14.
ChoiYB, TennetiL, LeDA, OrtizJ, BaiG, ChenHS, LiptonSA. Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation. Nat Neurosci, 3:15–21. 2000.
15.
ChristophersonKS, HillierBJ, LimWA, BredtDS. PSD-95 assembles a ternary complex with the N-methyl-d-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain. J Biol Chem, 274:27467–27473. 1999.
16.
ChuangDM, HoughC, SenatorovVV. Glyceraldehyde-3-phosphate dehydrogenase, apoptosis, and neurodegenerative diseases. Annu Rev Pharmacol Toxicol, 45:269–290. 2005.
17.
ChuangDM, LengY, MarinovaZ, KimHJ, ChiuCT. Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends Neurosci, 32:591–601. 2009.
18.
ChungKK. Modulation of pro-survival proteins by S-nitrosylation: implications for neurodegeneration. Apoptosis, 2010[Epub ahead of print].
19.
ChungKK, DavidKK. Emerging roles of nitric oxide in neurodegeneration. Nitric Oxide, 2010[Epub ahead of print].
CianiE, GuidiS, BartesaghiR, ContestabileA. Nitric oxide regulates cGMP-dependent cAMP-responsive element binding protein phosphorylation and Bcl-2 expression in cerebellar neurons: implication for a survival role of nitric oxide. J Neurochem, 82:1282–1289. 2002.
22.
ColellA, GreenDR, RicciJE. Novel roles for GAPDH in cell death and carcinogenesis. Cell Death Differ, 16:1573–1581. 2009.
23.
ColussiC, MozzettaC, GurtnerA, IlliB, RosatiJ, StrainoS, RagoneG, PescatoriM, ZaccagniniG, AntoniniA, MinettiG, MartelliF, PiaggioG, GallinariP, SteinkuhlerC, ClementiE, Dell'AversanaC, AltucciL, MaiA, CapogrossiMC, PuriPL, GaetanoC. HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment. Proc Natl Acad Sci U S A, 105:19183–19187. 2008.
24.
ContestabileA. Regulation of transcription factors by nitric oxide in neurons and in neural-derived tumor cells. Prog Neurobiol, 84:317–328. 2008.
25.
CorreiaSC, MoreiraPI. Hypoxia-inducible factor 1: a new hope to counteract neurodegeneration?J Neurochem, 112:1–12. 2010.
CummingRC, SchubertD. Amyloid-beta induces disulfide bonding and aggregation of GAPDH in Alzheimer's disease. FASEB J, 19:2060–2062. 2005.
28.
DawsonVL, DawsonTM, LondonED, BredtDS, SnyderSH. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci U S A, 88:6368–6371. 1991.
29.
DimmelerS, LottspeichF, BruneB. Nitric oxide causes ADP-ribosylation and inhibition of glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem, 267:16771–16774. 1992.
30.
DingH, DempleB. Direct nitric oxide signal transduction via nitrosylation of iron-sulfur centers in the SoxR transcription activator. Proc Natl Acad Sci U S A, 97:5146–5150. 2000.
31.
DouF, NetzerWJ, TanemuraK, LiF, HartlFU, TakashimaA, GourasGK, GreengardP, XuH. Chaperones increase association of tau protein with microtubules. Proc Natl Acad Sci U S A, 100:721–726. 2003.
32.
FangJ, NakamuraT, ChoDH, GuZ, LiptonSA. S-nitrosylation of peroxiredoxin 2 promotes oxidative stress-induced neuronal cell death in Parkinson's disease. Proc Natl Acad Sci U S A, 104:18742–18747. 2007.
ForresterMT, SethD, HausladenA, EylerCE, FosterMW, MatsumotoA, BenharM, MarshallHE, StamlerJS. Thioredoxin-interacting protein (Txnip) is a feedback regulator of S-nitrosylation. J Biol Chem, 284:36160–36166. 2009.
35.
FosterMW, HessDT, StamlerJS. Protein S-nitrosylation in health and disease: a current perspective. Trends Mol Med, 15:391–404. 2009.
36.
GarbanHJ, Marquez-GarbanDC, PietrasRJ, IgnarroLJ. Rapid nitric oxide-mediated S-nitrosylation of estrogen receptor: regulation of estrogen-dependent gene transcription. Proc Natl Acad Sci U S A, 102:2632–2636. 2005.
HaraMR, CascioMB, SawaA. GAPDH as a sensor of NO stress. Biochim Biophys Acta, 1762:502–509. 2006.
43.
HaraMR, SnyderSH. Nitric oxide-GAPDH-Siah: a novel cell death cascade. Cell Mol Neurobiol, 26:527–538. 2006.
44.
HaraMR, ThomasB, CascioMB, BaeBI, HesterLD, DawsonVL, DawsonTM, SawaA, SnyderSH. Neuroprotection by pharmacologic blockade of the GAPDH death cascade. Proc Natl Acad Sci U S A, 103:3887–3889. 2006.
45.
HardinghamGE. Pro-survival signalling from the NMDA receptor. Biochem Soc Trans, 34:936–938. 2006.
46.
HardinghamGE. Coupling of the NMDA receptor to neuroprotective and neurodestructive events. Biochem Soc Trans, 37:1147–1160. 2009.
47.
HausladenA, PrivalleCT, KengT, DeAngeloJ, StamlerJS. Nitrosative stress: activation of the transcription factor OxyR. Cell, 86:719–729. 1996.
48.
HenekaMT, FeinsteinDL. Expression and function of inducible nitric oxide synthase in neurons. J Neuroimmunol, 114:8–18. 2001.
49.
HermansonO, JepsenK, RosenfeldMG. N-CoR controls differentiation of neural stem cells into astrocytes. Nature, 419:934–939. 2002.
50.
HessDT, MatsumotoA, KimSO, MarshallHE, StamlerJS. Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Biol, 6:150–166. 2005.
51.
HisaharaS, ChibaS, MatsumotoH, HorioY. Transcriptional regulation of neuronal genes and its effect on neural functions: NAD-dependent histone deacetylase SIRT1 (Sir2alpha)J Pharmacol Sci, 98:200–204. 2005.
52.
HolscherC. Nitric oxide, the enigmatic neuronal messenger: its role in synaptic plasticity. Trends Neurosci, 20:298–303. 1997.
IlliB, ColussiC, GrasselliA, FarsettiA, CapogrossiMC, GaetanoC. NO sparks off chromatin: tales of a multifaceted epigenetic regulator. Pharmacol Ther, 123:344–352. 2009.
55.
IschiropoulosH. Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys, 356:1–11. 1998.
56.
IschiropoulosH. Protein tyrosine nitration—an update. Arch Biochem Biophys, 484:117–121. 2009.
57.
IshitaniR, ChuangDM. Glyceraldehyde-3-phosphate dehydrogenase antisense oligodeoxynucleotides protect against cytosine arabinonucleoside-induced apoptosis in cultured cerebellar neurons. Proc Natl Acad Sci U S A, 93:9937–9941. 1996.
58.
IshitaniR, KimuraM, SunagaK, KatsubeN, TanakaM, ChuangDM. An antisense oligodeoxynucleotide to glyceraldehyde-3-phosphate dehydrogenase blocks age-induced apoptosis of mature cerebrocortical neurons in culture. J Pharmacol Exp Ther, 278:447–454. 1996.
59.
IshitaniR, SunagaK, HiranoA, SaundersP, KatsubeN, ChuangDM. Evidence that glyceraldehyde-3-phosphate dehydrogenase is involved in age-induced apoptosis in mature cerebellar neurons in culture. J Neurochem, 66:928–935. 1996.
JaffreySR, Erdjument-BromageH, FerrisCD, TempstP, SnyderSH. Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat Cell Biol, 3:193–197. 2001.
KangYC, KimPK, ChoiBM, ChungHT, HaKS, KwonYG, KimYM. Regulation of programmed cell death in neuronal cells by nitric oxide. In Vivo, 18:367–376. 2004.
64.
KasperLH, FukuyamaT, BiesenMA, BoussouarF, TongC, dePauw A, MurrayPJ, van DeursenJM, BrindlePK. Conditional knockout mice reveal distinct functions for the global transcriptional coactivators CBP and p300 in T-cell development. Mol Cell Biol, 26:789–809. 2006.
65.
KerchnerGA, NicollRA. Silent synapses and the emergence of a postsynaptic mechanism for LTP. Nat Rev Neurosci, 9:813–825. 2008.
66.
KimCI, LeeSH, SeongGJ, KimYH, LeeMY. Nuclear translocation and overexpression of GAPDH by the hyper-pressure in retinal ganglion cell. Biochem Biophys Res Commun, 341:1237–1243. 2006.
67.
KitadaT, AsakawaS, HattoriN, MatsumineH, YamamuraY, MinoshimaS, YokochiM, MizunoY, ShimizuN. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature, 392:605–608. 1998.
68.
KleppischT, FeilR. cGMP signalling in the mammalian brain: role in synaptic plasticity and behaviour. Handb Exp Pharmacol, 191:549–579. 2009.
69.
KorzusE, RosenfeldMG, MayfordM. CBP histone acetyltransferase activity is a critical component of memory consolidation. Neuron, 42:961–972. 2004.
KouzaridesT. Chromatin modifications and their function. Cell, 128:693–705. 2007.
72.
KrumenackerJS, HanafyKA, MuradF. Regulation of nitric oxide and soluble guanylyl cyclase. Brain Res Bull, 62:505–515. 2004.
73.
KusnerLL, SarthyVP, MohrS. Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase: a role in high glucose-induced apoptosis in retinal Muller cells. Invest Ophthalmol Vis Sci, 45:1553–1561. 2004.
74.
LeeJR, KimJK, LeeSJ, KimKP. Role of protein tyrosine nitration in neurodegenerative diseases and atherosclerosis. Arch Pharm Res, 32:1109–1118. 2009.
75.
LiF, SonveauxP, RabbaniZN, LiuS, YanB, HuangQ, VujaskovicZ, DewhirstMW, LiCY. Regulation of HIF-1alpha stability through S-nitrosylation. Mol Cell, 26:63–74. 2007.
76.
LiptonSA. Neuronal protection and destruction by NO. Cell Death Differ, 6:943–951. 1999.
77.
LiptonSA, ChoiYB, PanZH, LeiSZ, ChenHS, SucherNJ, LoscalzoJ, SingelDJ, StamlerJS. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature, 364:626–632. 1993.
78.
LiptonSA, ChoiYB, TakahashiH, ZhangD, LiW, GodzikA, BankstonLA. Cysteine regulation of protein function—as exemplified by NMDA-receptor modulation. Trends Neurosci, 25:474–480. 2002.
79.
LuYF, KandelER, HawkinsRD. Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus. J Neurosci, 19:10250–10261. 1999.
80.
MaiA, RotiliD, ValenteS, KazantsevAG. Histone deacetylase inhibitors and neurodegenerative disorders: holding the promise. Curr Pharm Des, 15:3940–3957. 2009.
81.
MandelS, WeinrebO, AmitT, YoudimMB. Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives. Brain Res Brain Res Rev, 48:379–387. 2005.
82.
MarshallHE, StamlerJS. Inhibition of NF-kappa B by S-nitrosylation. Biochemistry, 40:1688–1693. 2001.
83.
Martinez-RuizA, VillanuevaL, Gonzalez deOrduna C, Lopez-FerrerD, HiguerasMA, TarinC, Rodriguez-CrespoI, VazquezJ, LamasS. S-nitrosylation of Hsp90 promotes the inhibition of its ATPase and endothelial nitric oxide synthase regulatory activities. Proc Natl Acad Sci U S A, 102:8525–8530. 2005.
84.
MaruyamaW, Oya-ItoT, Shamoto-NagaiM, OsawaT, NaoiM. Glyceraldehyde-3-phospate dehydrogenase is translocated into nuclei through Golgi apparatus during apoptosis induced by 6-hydroxydopamine in human dopaminergic SH-SY5Y cells. Neurosci Lett, 321:29–32. 2002.
85.
MattsonMP. Methylation and acetylation in nervous system development and neurodegenerative disorders. Ageing Res Rev, 2:329–342. 2003.
86.
MazzolaJL, SiroverMA. Alteration of nuclear glyceraldehyde-3-phosphate dehydrogenase structure in Huntington's disease fibroblasts. Brain Res Mol Brain Res, 100:95–101. 2002.
87.
MazzolaJL, SiroverMA. Subcellular alteration of glyceraldehyde-3-phosphate dehydrogenase in Alzheimer's disease fibroblasts. J Neurosci Res, 71:279–285. 2003.
88.
McCarthyMM. The two faces of estradiol: effects on the developing brain. Neuroscientist, 15:599–610. 2009.
89.
McDonaldLJ, MossJ. Stimulation by nitric oxide of an NAD linkage to glyceraldehyde-3-phosphate dehydrogenase. Proc Natl Acad Sci U S A, 90:6238–6241. 1993.
90.
MessmerUK, BruneB. Modification of macrophage glyceraldehyde-3-phosphate dehydrogenase in response to nitric oxide. Eur J Pharmacol, 302:171–182. 1996.
91.
MohrS, StamlerJS, BruneB. Posttranslational modification of glyceraldehyde-3-phosphate dehydrogenase by S-nitrosylation and subsequent NADH attachment. J Biol Chem, 271:4209–4214. 1996.
92.
Molinay, VediaL, McDonaldB, ReepB, BruneB, Di SilvioM, BilliarTR, LapetinaEG. Nitric oxide-induced S-nitrosylation of glyceraldehyde-3-phosphate dehydrogenase inhibits enzymatic activity and increases endogenous ADP-ribosylation. J Biol Chem, 267:24929–24932. 1992.
93.
MontanerJ, Alvarez-SabinJ, MolinaC, AnglesA, AbilleiraS, ArenillasJ, GonzalezMA, MonasterioJ. Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment. Stroke, 32:1759–1766. 2001.
94.
MothetJP, ParentAT, WoloskerH, BradyRO.Jr., LindenDJ, FerrisCD, RogawskiMA, SnyderSH. D-serine is an endogenous ligand for the glycine site of the N-methyl-d-aspartate receptor. Proc Natl Acad Sci U S A, 97:4926–4931. 2000.
95.
MurphyS. Production of nitric oxide by glial cells: regulation and potential roles in the CNS. Glia, 29:1–13. 2000.
96.
MustafaAK, KumarM, SelvakumarB, HoGP, EhmsenJT, BarrowRK, AmzelLM, SnyderSH. Nitric oxide S-nitrosylates serine racemase, mediating feedback inhibition of D-serine formation. Proc Natl Acad Sci U S A, 104:2950–2955. 2007.
97.
Nagai-KusuharaA, NakamuraM, MukunoH, KanamoriA, NegiA, SeigelGM. cAMP-responsive element binding protein mediates a cGMP/protein kinase G-dependent anti-apoptotic signal induced by nitric oxide in retinal neuro-glial progenitor cells. Exp Eye Res, 84:152–162. 2007.
98.
NakamuraT, LiptonSA. S-nitrosylation and uncompetitive/fast off-rate (UFO) drug therapy in neurodegenerative disorders of protein misfolding. Cell Death Differ, 14:1305–1314. 2007.
99.
NakamuraT, LiptonSA. Emerging roles of S-nitrosylation in protein misfolding and neurodegenerative diseases. Antioxid Redox Signal, 10:87–101. 2008.
100.
NakamuraT, LiptonSA. Cell death: protein misfolding and neurodegenerative diseases. Apoptosis, 14:455–468. 2009.
NottA, WatsonPM, RobinsonJD, CrepaldiL, RiccioA. S-nitrosylation of histone deacetylase 2 induces chromatin remodelling in neurons. Nature, 455:411–415. 2008.
105.
OikeY, TakakuraN, HataA, KanameT, AkizukiM, YamaguchiY, YasueH, ArakiK, YamamuraK, SudaT. Mice homozygous for a truncated form of CREB-binding protein exhibit defects in hematopoiesis and vasculo-angiogenesis. Blood, 93:2771–2779. 1999.
106.
OlanowCW. Rationale for considering that propargylamines might be neuroprotective in Parkinson's disease. Neurology, 66:S69–S79. 2006.
107.
OuXM, LuD, JohnsonC, ChenK, YoudimMB, RajkowskaG, ShihJC. Glyceraldehyde-3-phosphate dehydrogenase-monoamine oxidase B-mediated cell death-induced by ethanol is prevented by rasagiline and 1-R-aminoindan. Neurotox Res, 16:148–159. 2009.
108.
OuXM, StockmeierCA, MeltzerHY, OverholserJC, JurjusGJ, DieterL, ChenK, LuD, JohnsonC, YoudimMB, AustinMC, LuoJ, SawaA, MayW, ShihJC. A novel role for glyceraldehyde-3-phosphate dehydrogenase and monoamine oxidase B cascade in ethanol-induced cellular damage. Biol Psychiatry, 67:855–863. 2010.
ReiterTA. NO* chemistry: a diversity of targets in the cell. Redox Rep, 11:194–206. 2006.
116.
ReynaertNL, CklessK, KornSH, VosN, GualaAS, WoutersEF, van derVliet A, Janssen-HeiningerYM. Nitric oxide represses inhibitory kappaB kinase through S-nitrosylation. Proc Natl Acad Sci U S A, 101:8945–8950. 2004.
RosellA, Ortega-AznarA, Alvarez-SabinJ, Fernandez-CadenasI, RiboM, MolinaCA, LoEH, MontanerJ. Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke. Stroke, 37:1399–1406. 2006.
119.
RothSY, DenuJM, AllisCD. Histone acetyltransferases. Annu Rev Biochem, 70:81–120. 2001.
120.
RubboH, RadiR. Protein and lipid nitration: role in redox signaling and injury. Biochim Biophys Acta, 1780:1318–1324. 2008.
121.
SahaRN, PahanK. HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis. Cell Death Differ, 13:539–550. 2006.
122.
SaundersPA, Chalecka-FranaszekE, ChuangDM. Subcellular distribution of glyceraldehyde-3-phosphate dehydrogenase in cerebellar granule cells undergoing cytosine arabinoside-induced apoptosis. J Neurochem, 69:1820–1828. 1997.
123.
SaundersPA, ChenRW, ChuangDM. Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase isoforms during neuronal apoptosis. J Neurochem, 72:925–932. 1999.
124.
SawaA, KhanAA, HesterLD, SnyderSH. Glyceraldehyde-3-phosphate dehydrogenase: nuclear translocation participates in neuronal and nonneuronal cell death. Proc Natl Acad Sci U S A, 94:11669–11674. 1997.
125.
SelvakumarB, HuganirRL, SnyderSH. S-nitrosylation of stargazin regulates surface expression of AMPA-glutamate neurotransmitter receptors. Proc Natl Acad Sci U S A, 106:16440–16445. 2009.
126.
SenN, HaraMR, AhmadAS, CascioMB, KamiyaA, EhmsenJT, AgrawalN, HesterL, DoreS, SnyderSH, SawaA. GOSPEL: a neuroprotective protein that binds to GAPDH upon S-nitrosylation. Neuron, 63:81–91. 2009.
ShepherdJD, HuganirRL. The cell biology of synaptic plasticity: AMPA receptor trafficking. Annu Rev Cell Dev Biol, 23:613–643. 2007.
129.
ShiozawaM, FukutaniY, AraiN, CairnsNJ, MizutaniT, IsakiK, LantosPL, WadaY. Glyceraldehyde 3-phosphate dehydrogenase and endothelin-1 immunoreactivity is associated with cerebral white matter damage in dentatorubral-pallidoluysian atrophy. Neuropathology, 23:36–43. 2003.
130.
SiroverMA. New nuclear functions of the glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in mammalian cells. J Cell Biochem, 95:45–52. 2005.
131.
SouzaJM, PeluffoG, RadiR. Protein tyrosine nitration—functional alteration or just a biomarker?Free Radic Biol Med, 45:357–366. 2008.
132.
SparyEJ, MaqboolA, BattenTF. Oestrogen receptors in the central nervous system and evidence for their role in the control of cardiovascular function. J Chem Neuroanat, 38:185–196. 2009.
133.
StamlerJS. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell, 78:931–936. 1994.
StrahlBD, AllisCD. The language of covalent histone modifications. Nature, 403:41–45. 2000.
136.
TabakmanR, LechtS, LazaroviciP. Neuroprotection by monoamine oxidase B inhibitors: a therapeutic strategy for Parkinson's disease?Bioessays, 26:80–90. 2004.
137.
TanakaR, MochizukiH, SuzukiA, KatsubeN, IshitaniR, MizunoY, UrabeT. Induction of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) expression in rat brain after focal ischemia/reperfusion. J Cereb Blood Flow Metab, 22:280–288. 2002.
138.
TannenbaumSR, WhiteFM. Regulation and specificity of S-nitrosylation and denitrosylation. ACS Chem Biol, 1:615–618. 2006.
139.
TattonNA. Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease. Exp Neurol, 166:29–43. 2000.
140.
TattonW, Chalmers-RedmanR, TattonN. Neuroprotection by deprenyl and other propargylamines: glyceraldehyde-3-phosphate dehydrogenase rather than monoamine oxidase B. J Neural Transm, 110:509–515. 2003.
141.
TennetiL, D'EmiliaDM, LiptonSA. Suppression of neuronal apoptosis by S-nitrosylation of caspases. Neurosci Lett, 236:139–142. 1997.
142.
ThiagalingamS, ChengKH, LeeHJ, MinevaN, ThiagalingamA, PonteJF. Histone deacetylases: unique players in shaping the epigenetic histone code. Ann N Y Acad Sci, 983:84–100. 2003.
143.
TsangAH, LeeYI, KoHS, SavittJM, PletnikovaO, TroncosoJC, DawsonVL, DawsonTM, ChungKK. S-nitrosylation of XIAP compromises neuronal survival in Parkinson's disease. Proc Natl Acad Sci U S A, 106:4900–4905. 2009.
144.
TsuchiyaK, TajimaH, YamadaM, TakahashiH, KuwaeT, SunagaK, KatsubeN, IshitaniR. Disclosure of a pro-apoptotic glyceraldehyde-3-phosphate dehydrogenase promoter: anti-dementia drugs depress its activation in apoptosis. Life Sci, 74:3245–3258. 2004.
145.
UeharaT, NakamuraT, YaoD, ShiZQ, GuZ, MaY, MasliahE, NomuraY, LiptonSA. S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature, 441:513–517. 2006.
146.
VerdierY, FoldiI, SergeantN, FulopL, PenkeZ, JanakyT, SzucsM, PenkeB. Characterization of the interaction between Abeta 1–42 and glyceraldehyde phosphodehydrogenase. J Pept Sci, 14:755–762. 2008.
147.
WaldmeierPC, BoultonAA, CoolsAR, KatoAC, TattonWG. Neurorescuing effects of the GAPDH ligand CGP 3466B. J Neural Transm Suppl, 60:197–214. 2000.
148.
YaoD, GuZ, NakamuraT, ShiZQ, MaY, GastonB, PalmerLA, RockensteinEM, ZhangZ, MasliahE, UeharaT, LiptonSA. Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity. Proc Natl Acad Sci U S A, 101:10810–10814. 2004.
ZhangJ, SnyderSH. Nitric oxide stimulates auto-ADP-ribosylation of glyceraldehyde-3-phosphate dehydrogenase. Proc Natl Acad Sci U S A, 89:9382–9385. 1992.
